Colgate Cavity Protection

PreclinicalSmall molecule

GSK

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Dental PlaqueCompleted

Dental PlaquePreclinical

Completed

Clinical

Trials by Indication[1]

Dentinal Hypersensitivity1 trial

Study to Evaluate the Effectiveness of Test Dentifrice in the Relief of Dentinal Hypersensitivity

Completed·HHALEON·N/A·NCT07317128·120 enrolled

Plaque1 trial

Metagenomic and Metatranscriptomic Analysis of Clinical Plaque Samples

Completed·CColgate Palmolive·Phase 2·NCT05138978·34 enrolled

Efficacy1 trial

A Clinical Study Investigating the Efficacy of a Stannous Fluoride Dentifrice in Improving Gingival Health After Twice Daily Use for 3 Weeks

Completed· GSK logo

GSK·Phase 4·NCT04050722·130 enrolled

Metabolism1 trial

Arginine Plaque Metabolism Pilot Clinical Study

Completed·CColgate Palmolive·Phase 3·NCT06954779·20 enrolled

AIN1 trial

Clinical Study of Toothpaste Containing Zinc Lactate as Compared to Colgate Cavity Protection Toothpaste.

Completed·CColgate Palmolive·Phase 2·NCT06563518·92 enrolled

2 more indications

Dentin Sensitivity1 trial

Clinical Study to Investigate the Ability of a Stannous Fluoride Toothpaste to Protect From Dentine Hypersensitivity

Completed·HHALEON·Preclinical·NCT06733285·85 enrolled

Dental Plaque1 trial

A 24-Week, Randomised, Controlled, Examiner-blind, Clinical Study to Evaluate the Efficacy of an Experimental Stannous Fluoride Dentifrice in Improving Gingival Health and Reducing Plaque Accumulation

Completed·HHALEON·Preclinical·NCT07255040·284 enrolled

Sources

References

[1]
ClinicalTrials.gov — 7 trial records for Colgate Cavity Protection. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Colgate Cavity Protection compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Colgate Cavity Protection. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: GSK